Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms ALT-PG3 |
Target |
Mechanism EPHX2 inhibitors(Epoxide hydratase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC46H53F3N6O14 |
InChIKeySTGMSTZSBJPAMZ-YRLQYNNYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | ES | 10 Oct 2023 | |
Inflammation | Preclinical | ES | 10 Oct 2023 | |
Inflammation | Preclinical | ES | 10 Oct 2023 |